Brief: New Positive Donidalorsen Data To Be Presented At Aaaai/Wao Joint Congress
20/02/2025 12:15
Feb 20 (Reuters) - Ionis Pharmaceuticals Inc IONS.O :
* NEW POSITIVE DONIDALORSEN DATA TO BE PRESENTED AT
AAAAI/WAO
JOINT CONGRESS HIGHLIGHT SUSTAINED HAE ATTACK RATE REDUCTION AND
DISEASE CONTROL
Source text: ID:nBw7Nkf93a
Further company coverage: IONS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ionis Pharmaceuticals
See all newsAnalysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
Brief: Ionis Announces License Agreement With Recordati For Zilganersen In Alexander Disease (Axd) In All Countries Outside The U.S.
Brief: Ionis Pharmaceuticals Says FDA Approved Tryngolza For Severe Hypertriglyceridemia
Brief: FDA Approves Treatment To Reduce Risk Of Acute Pancreatitis In Adults With Severe Hypertriglyceridemia
Brief: Ionis Announces Appointment Of Ludwig Hantson, Ph.D. To Board Of Directors